+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 1h30 | ||||||
---|---|---|---|---|---|---|---|
タイトル | C-terminal LG domain pair of human Gas6 | ||||||
要素 | GROWTH-ARREST-SPECIFIC PROTEIN | ||||||
キーワード | LAMININ G-DOMAIN PROTEIN / VITAMIN K-DEPENDENT PROTEIN / AXL/SKY/MER LIGAND / LAMININ G- LIKE DOMAIN / EGF-LIKE DOMAIN / CALCIUM-BINDING | ||||||
機能・相同性 | 機能・相同性情報 negative regulation of oligodendrocyte apoptotic process / negative regulation of renal albumin absorption / cellular response to vitamin K / positive regulation of glomerular filtration / positive regulation of natural killer cell differentiation / hematopoietic stem cell migration to bone marrow / B cell chemotaxis / cellular response to interferon-alpha / positive regulation of dendritic cell chemotaxis / myeloid cell apoptotic process ...negative regulation of oligodendrocyte apoptotic process / negative regulation of renal albumin absorption / cellular response to vitamin K / positive regulation of glomerular filtration / positive regulation of natural killer cell differentiation / hematopoietic stem cell migration to bone marrow / B cell chemotaxis / cellular response to interferon-alpha / positive regulation of dendritic cell chemotaxis / myeloid cell apoptotic process / extracellular matrix assembly / positive regulation of cytokine-mediated signaling pathway / negative regulation of interleukin-1 production / dendritic cell differentiation / negative regulation of biomineral tissue development / negative regulation of myeloid cell apoptotic process / negative regulation of dendritic cell apoptotic process / negative regulation of fibroblast apoptotic process / fibroblast apoptotic process / apoptotic cell clearance / cell-substrate adhesion / enzyme-linked receptor protein signaling pathway / phosphatidylserine binding / negative regulation of interleukin-6 production / cysteine-type endopeptidase inhibitor activity involved in apoptotic process / negative regulation of type II interferon production / negative regulation of tumor necrosis factor production / negative regulation of tumor necrosis factor-mediated signaling pathway / positive regulation of TOR signaling / positive regulation of protein kinase activity / animal organ regeneration / Gamma-carboxylation of protein precursors / Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus / negative regulation of endothelial cell apoptotic process / Removal of aminoterminal propeptides from gamma-carboxylated proteins / phagocytosis / positive regulation of phagocytosis / activation of protein kinase B activity / cellular response to starvation / viral genome replication / : / positive regulation of protein export from nucleus / platelet alpha granule lumen / protein localization to plasma membrane / Post-translational protein phosphorylation / Cell surface interactions at the vascular wall / cellular response to glucose stimulus / calcium ion transmembrane transport / neuron migration / cellular response to growth factor stimulus / receptor tyrosine kinase binding / Golgi lumen / Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) / positive regulation of fibroblast proliferation / blood coagulation / cellular response to xenobiotic stimulus / Platelet degranulation / protein-macromolecule adaptor activity / positive regulation of ERK1 and ERK2 cascade / positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction / receptor-mediated virion attachment to host cell / cell surface receptor signaling pathway / receptor ligand activity / symbiont entry into host cell / positive regulation of protein phosphorylation / protein phosphorylation / endoplasmic reticulum lumen / fusion of virus membrane with host plasma membrane / signaling receptor binding / negative regulation of DNA-templated transcription / calcium ion binding / positive regulation of gene expression / negative regulation of apoptotic process / signal transduction / extracellular space / extracellular exosome / extracellular region / cytoplasm 類似検索 - 分子機能 | ||||||
生物種 | HOMO SAPIENS (ヒト) | ||||||
手法 | X線回折 / シンクロトロン / 単一同系置換・異常分散 / 解像度: 2.2 Å | ||||||
データ登録者 | Sasaki, T. / Knyazev, P.G. / Cheburkin, Y. / Gohring, W. / Tisi, D. / Ullrich, A. / Timpl, R. / Hohenester, E. | ||||||
引用 | ジャーナル: J.Biol.Chem. / 年: 2002 タイトル: Crystal Structure of a Carboxy-Terminal Fragment of Growth-Arrest-Specific Protein Gas6: Receptor Tyrosine Kinase Activation by Laminin G-Like Domains 著者: Sasaki, T. / Knyazev, P.G. / Cheburkin, Y. / Gohring, W. / Tisi, D. / Ullrich, A. / Timpl, R. / Hohenester, E. #1: ジャーナル: J.Biol.Chem. / 年: 1996 タイトル: Characterization of Gas6, a Member of the Superfamily of G Domain-Containing Proteins, as a Ligand for Rse and Axl 著者: Mark, M.R. / Chen, J. / Hammond, R.G. / Sadick, M. / Godowski, P.J. | ||||||
履歴 |
| ||||||
Remark 700 | SHEET THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN ORDER TO REPRESENT THIS FEATURE IN ... SHEET THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, TWO SHEETS ARE DEFINED. |
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 1h30.cif.gz | 88.6 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb1h30.ent.gz | 71.2 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 1h30.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 1h30_validation.pdf.gz | 442.5 KB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 1h30_full_validation.pdf.gz | 453.2 KB | 表示 | |
XML形式データ | 1h30_validation.xml.gz | 18 KB | 表示 | |
CIF形式データ | 1h30_validation.cif.gz | 24.7 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/h3/1h30 ftp://data.pdbj.org/pub/pdb/validation_reports/h3/1h30 | HTTPS FTP |
-関連構造データ
-リンク
-集合体
登録構造単位 |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
|
-要素
#1: タンパク質 | 分子量: 46615.352 Da / 分子数: 1 / 断片: C-TERMINAL LG DOMAIN PAIR, RESIDUES 261-678 / 由来タイプ: 組換発現 / 由来: (組換発現) HOMO SAPIENS (ヒト) / 細胞株 (発現宿主): 293-EBNA / 発現宿主: HOMO SAPIENS (ヒト) / 参照: UniProt: Q14393 | ||||||
---|---|---|---|---|---|---|---|
#2: 化合物 | ChemComp-CA / | ||||||
#3: 化合物 | #4: 水 | ChemComp-HOH / | 構成要素の詳細 | THE GROWTH ARREST-SPECIFIC PROTEIN IS A NEGATIVE REGULATOR IN THE BLOOD COAGULATIO | 配列の詳細 | N-TERMINAL APLA SEQUENCE IS VECTOR-DERIVED | |
-実験情報
-実験
実験 | 手法: X線回折 / 使用した結晶の数: 1 |
---|
-試料調製
結晶 | マシュー密度: 3.62 Å3/Da / 溶媒含有率: 65 % | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | pH: 7.5 / 詳細: pH 7.50 | |||||||||||||||||||||||||||||||||||||||||||||||||
結晶化 | *PLUS 手法: 蒸気拡散法, ハンギングドロップ法 | |||||||||||||||||||||||||||||||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: シンクロトロン / サイト: SRS / ビームライン: PX9.6 / 波長: 0.87 |
検出器 | 検出器: CCD / 日付: 2000年3月15日 |
放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 0.87 Å / 相対比: 1 |
反射 | 解像度: 2.2→20 Å / Num. obs: 35018 / % possible obs: 99.8 % / 冗長度: 5 % / Rmerge(I) obs: 0.082 / Net I/σ(I): 14.8 |
反射 シェル | 解像度: 2.2→2.32 Å / 冗長度: 5 % / Rmerge(I) obs: 0.297 / Mean I/σ(I) obs: 3.9 / % possible all: 100 |
反射 | *PLUS 最低解像度: 20 Å |
反射 シェル | *PLUS 最高解像度: 2.2 Å / % possible obs: 100 % |
-解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: 単一同系置換・異常分散 / 解像度: 2.2→20 Å / Data cutoff high absF: 10000 / Isotropic thermal model: RESTRAINED / 交差検証法: THROUGHOUT / σ(F): 0
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | 溶媒モデル: FLAT / Bsol: 48.6 Å2 / ksol: 0.366 e/Å3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.2→20 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 | *PLUS 最低解像度: 20 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS |